Healium Closes $3.6M Seed Funding


Healium, a Columbia, MO-based virtual and augmented reality biofeedback company, closed a $3.6m seed funding round.

Participating funds included Impact Venture Capital, Ambition Fund II, Captain Partners & Astronaut Holdings, Citrine Angels, Coact Capital, Gaingels, KCRise Fund, Mayo Clinic, Missouri Technology Corporation, QRM Capital, Stadia Ventures, Tidewater Capital, and Underdog Ventures.

The company is using the funds to expand operations and its development efforts.

Led by Sarah Hill, CEO, who developed the technology with Dr. Jeff Tarrant in 2016, Healium is advancing patented technology that connects bio-data from hardware-agnostic consumer wearables to modify and recommend 3D objects in the metaverse. Its products including Sleepium allow users to learn to self-regulate their anxiety by giving them the ability to see their EEG brain patterns or heart rate personified in real-time. Healium’s products and patented technologies bring biometric data from fitness trackers to life inside virtual, augmented, or mixed reality stories so the user can see and interact with their own EEG brain patterns, heart rate, skin conductance, blood pressure or other biomarkers. The products including Sleepium are used worldwide in schools, with frontline healthcare workers, elite athletes, and the US military to self-manage anxiety, burnout, and downshift the nervous system before sleep or stressful events.

Healium’s IOS and Android mobile apps are currently compatible with Apple Watch (iphone) and consumer grade EEG headbands with more fitness trackers coming soon.

The company also entered into a know-how agreement with Mayo Clinic, which will provide subject matter experts to assist in the development of immersive mental health and fitness capabilities utilizing virtual and augmented reality.